DiscoverCAPcast from the College of American PathologistsApplying Liquid Biopsies to Cancer Biomarkers in Circulating Tumors
Applying Liquid Biopsies to Cancer Biomarkers in Circulating Tumors

Applying Liquid Biopsies to Cancer Biomarkers in Circulating Tumors

Update: 2023-11-20
Share

Description

The liquid biopsy has rapidly emerged as a method to minimize the amount of tissue needed for testing, making it a less invasive and safer alternative to more traditional procedures. As it continues to evolve, liquid biopsies offer exciting new options in the practice of pathology. In this episode, Maria Arcila, MD, FCAP, and JinJuan Yao, MD, FCAP, discuss the development of this new diagnostic tool.

CAP Precision Medicine Resource Center: https://www.cap.org/member-resources/precision-medicine

CAP and AMP recommendations on validation of cell-free DNA assays: https://www.jmdjournal.org/article/S1525-1578%2823%2900219-2/fulltext
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Applying Liquid Biopsies to Cancer Biomarkers in Circulating Tumors

Applying Liquid Biopsies to Cancer Biomarkers in Circulating Tumors

College of American Pathologists